David Spigel, MD

Chief Scientific Officer; Director
Lung Cancer Research Program
Sarah Cannon Research Institute
Nashville, TN

Authored Items

Combination Therapies and New Molecular Targets—Presentations from AACR 2021
By David Spigel, MD
American Association for Cancer Research (AACR)
AACR & ASCO 2021 – Midyear Review
Dr David Spigel reviews potentially practice-changing data on EGFR-TKI combination therapies in NSCLC, new approaches to advanced NSCLC and CNS involvement, and hopeful early data with novel targeted agents. Read More ›
Exciting New Data Presented on NSCLC at AACR 2021
By David Spigel, MD
American Association for Cancer Research (AACR)
AACR & ASCO 2021 – Midyear Review
Dr David Spigel discusses key presentations on immunotherapy and targeted therapy in the neoadjuvant and adjuvant settings in NSCLC. Read More ›
Conference Correspondent Coverage is Brought to You by the Publishers of:
American Health & Drug Benefits
Journal of Hematology Oncology Pharmacy
Journal of Oncology Navigation & Survivorship
Oncology Practice Management
Personalized Medicine in Oncology

Learn more about our family of publications.

View Our Publications

© Amplity Health. All Rights Reserved. Privacy Policy